Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.43.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.43.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.43.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.43.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.43.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.43.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.43.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.43.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EU.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EU.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EU.1.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EU.1.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EU.1.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EU.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EU.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.18ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.48EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.48ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.48ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.48EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.48EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.48ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.39EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.39ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.39ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.39EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.39EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EE.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EE.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used